Acquisition of C/D/N Isotopes by LGC

Deal typePrivate Equity & Transaction Services
IndustryLife Sciences
Client nameLGC (Holdings) Limited

BDO advised on the acquistion by LGC of C/D/N isotopes (CDN), a leading manufacturer and provider of deuterium-labelled compounds. We provided financial due diligence on the target business. 

CDN's line of products is highly complementary with LGC's existing analytical standard and reference material businesses and will build up LGC's position in the deuterated market.

LGC is a global leader in the life sciences sector, serving customers in healthcare, applied markets (including food, agbio and the environment), research and government.